ACE2 and diabetic kidney disease: Modulating the activity and/or expression of ACE2 is a promising therapeutic approach for diabetic nephropathy due to the ability of ACE2 to both degrade Ang II and generate Ang 1-7 (Oudit et al., 2010; Shiota et al., 2010; Liu et al., 2011).